Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06593470

Mindfulness-Based Substance Use Prevention (MINDS-UP)

The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The main questions it aims to answer are:

1. Is MINDS-UP feasible and what is its preliminary efficacy? 2. Are MRI protocol and procedures feasible?

An additional exploratory question is:

Are there neural and psychopathological mechanisms through which MINDS-UP might work?

Researchers will compare Sport - Prevention Plus Wellness (PPW) (an evidence based substance use prevention program) to Sport - Prevention Plus Wellness + MINDS-UP to examine the preliminary efficacy of MINDS-UP.

Participants will

* take assessment #1 * have 2 MRIs and take MINDS-UP, just take MINDS-UP or have a delayed start * take assessment #2 * take PPW, a single remote and research assistant-delivered 45-minute session * take assessment #3 * take assessment #4

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

10 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
  • Access to a smart phone, tablet, or computer with Wi-Fi
  • English-speaking

Exclusion criteria

  • Has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
  • Youth is actively involved in another Boricua Youth Study (BYS)
  • Youth's sibling is or has previously been enrolled in MINDS-UP.

Treatment and study plan

MINDS-UP

Behavioral

MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

Prevention Plus Wellness

Behavioral

PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.

Other names: PPW

fMRI

Diagnostic Test

Functional MRI to investigate preliminary neural mechanisms of MINDS-UP

Primary outcomes

  1. Teacher Rated Participation

    Time frame: Completion of Study (up to 36 months)

    Research Assessment Package for Schools - Teacher Rated

  2. Acceptability

    Time frame: Completion of Study (up to 36 months)

    Acceptability of Intervention Measure

  3. Retention

    Time frame: Completion of Study (up to 36 months)

    Percent of participants who completed all study procedures among those who were randomized

  4. Attendance

    Time frame: Completion of Study (up to 36 months)

    Percent of scheduled sessions that were completed by the participant.

  5. Homework Completion

    Time frame: Completion of Study (up to 36 months)

    Percentage of assigned homeworks that were completed by the participant.

  6. Participation (student)

    Time frame: Completion of Study (up to 36 months)

    Research Assessment Package for Schools - Student Engagement

Secondary outcomes

  1. MRI retention

    Time frame: Completion of Study (up to 36 months)

    Percentage of participants randomized to receive MRI that complete both MRIs

  2. Future MRI endorsement

    Time frame: Completion of Study (up to 36 months)

    Percentage of participants who endorse willingness to undergo a future research MRI scan

  3. Anxiety and Depression

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains.

  4. Mindfulness

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness

  5. Externalizing Problems (parent-report)

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems

  6. Externalizing Problems (self-report)

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the externalizing problems subscale on the Youth Self Report, which is comprised of 112 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems

  7. Total Problems (self-report)

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale Youth Self Report; the survey is comprised of 112 items, with individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems

  8. Total Problems (parent-report)

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems

  9. Cannabis Use

    Time frame: 4-6 weeks, 6 months, and 12 months

    Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis.

  10. Alcohol sipping

    Time frame: 4-6 weeks, 6 months, and 12 months

    Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip.

  11. Tobacco Use

    Time frame: 4-6 weeks, 6 months, and 12 months

    Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use.

  12. ADHD Symptoms

    Time frame: 4-6 weeks, 6 months, and 12 months

    Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems

Study contacts

Contact information is provided by the study sponsor or research team.

David C Saunders, MD, PhD

CONTACT

[email protected]

914-409-6807

Sponsors and collaborators

Lead sponsor

New York State Psychiatric Institute

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Mindfulness-Based Substance Use Prevention (MINDS-UP): a Randomized Controlled Trial

Acronym: MINDS-UP

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 19, 2024
Registry last updated
Apr 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.